Incidence and prognostic significance of second primary cancers in renal cell carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 2, 2013, Pages 132-142

  Chakraborty, Subhankar ^a   Tarantolo, Stefano R ^b   Batra, Surinder K ^a,c   Hauke, Ralph J ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Nebraska Cancer Specialists   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

prognosis; renal cell carcinoma; second primary; SEER

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CHILD; DIGESTIVE SYSTEM CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PROSTATE CANCER; RACE; RESPIRATORY TRACT CANCER; SCHOOL CHILD; SECOND CANCER; SEX DIAGNOSIS; SOLID TUMOR;

ADULT; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RISK; SURVIVAL ANALYSIS;

EID: 84876109573     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182438ddf     Document Type: Article

References (38)

1. American Cancer Society. Cancer Facts & Figures 2010. Atlanta. American Cancer Society; 2010.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
3. Lipworth L, Tarone RE, McLaughlin JK. Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer. 2011;11:133.
4. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
5. Satram-Hoang S, Ziogas A, Nton-Culver H. Risk of second primary cancer in men with breast cancer. Breast Cancer Res. 2007;9:R10.
6. Noura S, Ohue M, Seki Y, et al. Second primary cancer in patients with colorectal cancer after a curative resection. Dig Surg. 2009;26:400-405.
7. Okamoto N, Morio S, Inoue R, et al. The risk of a second primary cancer occurring in five-year survivors of an initial cancer. Jpn J Clin Oncol. 1987;17:205-213.
8. Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008;123: 2390-2396.
9. Chuang SC, Hashibe M, Scelo G, et al. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 2008; 17:1543-1549.
10. Jones AS, Morar P, Phillips DE, et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343-1353.
11. Liu YY, Chen YM, Yen SH, et al. Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis. Lung Cancer. 2002;35:189-194.
12. Beisland C, Talleraas O, Bakke A, et al. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU Int. 2006;97:698-702.
13. Rabbani F, Reuter VE, Katz J, et al. Second primary malignancies associated with renal cell carcinoma: influence of histologic type. Urology. 2000;56:399-403.
14. Thompson RH, Leibovich BC, Cheville JC, et al. Second primary malignancies associated with renal cell carcinoma histological subtypes. J Urol. 2006;176:900-903.
15. Rixe O, Rini B. Renal cell carcinoma: ten years of significant advances. Target Oncol. 2010;5:73-74.
16. Rini BI, Campbell SC, Rathmell WK. Renal cell carcinoma. Curr Opin Oncol. 2006;18:289-296.
17. Tucker MA, Jones PH, Boice JD Jr, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res. 1991;51:2885-2888.
18. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98:1528-1537.
19. Ronckers CM, Sigurdson AJ, Stovall M, et al. Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers. Radiat Res. 2006;166:618-628.
20. Yu H, Harris RE, Gao YT, et al. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol. 1991; 20: 76-81.
21. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000; 85:60-67.
22. Koyama K, Furukawa Y, Tanaka H. Multiple primary malignant neoplasms in urologic patients. Scand J Urol Nephrol. 1995;29:483-490.
23. Turkic M, Znaor A, Novosel I, et al. [Second primary malignant tumors in patients with primary renal cell carcinoma]. Acta Med Croatica. 2005;59:91-95.
24. McCredie M, Macfarlane GJ, Stewart J, et al. Second primary cancers following cancers of the kidney and prostate in New South Wales (Australia), 1972-91. Cancer Causes Control. 1996;7:337-344.
25. Storm HH, Lynge E, Osterlind A, et al. Multiple primary cancers in Denmark 1943-80; influence of possible underreporting and suggested risk factors. Yale J Biol Med. 1986;59:547-559.
26. Malchoff CD, Sarfarazi M, Tendler B, et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab. 2000;85:1758-1764.
27. Morikawa Y, Shiomi K, Ishihara Y, et al. Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker. Am J Ind Med. 1997;31:44-49.
28. Czene K, Hemminki K. Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies. Kidney Int. 2002;61:1806-1813.
29. Cybulski C, Gorski B, Huzarski T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet. 2004;75:1131-1135.
30. Linehan WM, Vasselli J, Srinivasan R, et al. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res. 2004;10:6282S-6289S.
31. Valeri A, Borrelli A, Presenti L, et al. Adrenal masses in neoplastic patients: the role of laparoscopic procedure. Surg Endosc. 2001; 15:90-93.
32. Raabe NK, Fossa SD, Bjerkehagen B. Carcinoma of the renal pelvis. Experience of 80 cases. Scand J Urol Nephrol. 1992; 26:357-361.
33. Patel NP, Lavengood RW. Renal cell carcinoma: natural history and results of treatment. J Urol. 1978;119:722-726.
34. Manon R, O'Neill A, Knisely J, et al. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol. 2005;23: 8870-8876.
35. Brouwers AH, Mulders PF, de Mulder PH, et al. Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma. J Clin Oncol. 2005;23:6540-6548.
36. Aron M, Nguyen MM, Stein RJ, et al. Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol. 2008;54:133-140.
37. Choueiri TK, Baz RC, McFadden CM, et al. An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications. BJU Int. 2008;101:712-715.
38. Hartley AL, Birch JM, Blair V, et al. Second primary neoplasms in a population-based series of patients diagnosed with renal tumours in childhood. Med Pediatr Oncol. 1994;22:318-324.